Wenbin Qian
0000-0002-9817-6674
10 papers found
Refreshing results…
Tumor-Infiltrating Normal B Cells Revealed by Immunoglobulin Repertoire Clonotype Analysis Are Highly Prognostic and Crucial for Antitumor Immune Responses in DLBCL
Optimal model establishment of whole-process management data for CAR-T therapy in China—how should this be done?
Nocardia farcinica Brain Abscess in a Multiple Myeloma Patient Treated with Proteasome Inhibitor: A Case Report and Review of the Literature
Treatment-Related Adverse Events of Chimeric Antigen Receptor T-Cell (CAR T) in Clinical Trials: A Systematic Review and Meta-Analysis
CD70‐targeting CAR‐T cells have potential activity against CD19‐negative B‐cell Lymphoma
Natural killer cells associated with SARS-CoV-2 viral RNA shedding, antibody response and mortality in COVID-19 patients
Molecular insights into pathogenesis and targeted therapy of peripheral T cell lymphoma
The model of cytokine release syndrome in CAR T-cell treatment for B-cell non-Hodgkin lymphoma
SARS-CoV-2 induced thrombocytopenia as an important biomarker significantly correlated with abnormal coagulation function, increased intravascular blood clot risk and mortality in COVID-19 patients
Risk of HBV reactivation post CD19-CAR-T cell therapy in DLBCL patients with concomitant chronic HBV infection
Missing publications? Search for publications with a matching author name.